Uncategorized

Botox has a Strong Contender! Introducing Xeomin

By November 1, 2011 No Comments

Xeomin, which is manufactured by Merz Pharmaceuticals, is the latest competitor in a rapidly expanding list of botulinum toxin type A injectables. The Food and Drug Administration (FDA) approved Xeomin in July 2011 for the treatment of severe frown lines (glabellar lines )  between the eyes. This Botox alternative was already approved for use in adults with cervical dystonia, which  is characterized by abnormal neck pain and movements. Xeomin has also been appproved for blepharospasm, which is marked by abnormal, involuntary blinking or spasm of the eyelids.

With the new cosmetic approval, Xeomin is now in the running with Botox and Dysport to decrease wrinkles and help many stay looking young.  America is actually the 20th country to approve this drug.

How Xeomin Compares and Differs

Xeomin, Dysport and Botox are approved neurotoxins that are quite similar, but they do have some contrast. The differences probably mean more to the physician than the patient. For example, Xeomin is the only one of the three that does not need to be refrigerated before use, though once reconstituted, it must.

Just like that of Botox, effects of Xeomin occur within one week, and the results last from three to six months. The price is comparable to Botox and same with patient satisfaction.

Give Xeomin a chance and watch your wrinkles disappear. As a thank you from Merz Aesthetics, they are offering a $50 American Express Card after you have tried your first injection with Xeomin.

So what do you have to lose?  Call us for your treatment of Xeomin today!!!!!

310.853.5147